Odyssey Health annual r&d spending
2019
2020
2021
2022
2023
2024
2025
Odyssey Health R&D Spending Growth & History (ODYY)
Odyssey Health's r&d spending was $0 for fiscal 2025.
View full Odyssey Health company overviewOdyssey Health annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-07-31 | $0 | $0 | — |
| 2024 | 2024-07-31 | $0 | −$170,000 | — |
| 2023 | 2023-07-31 | $170,000 | −$1.1M | −87.09% |
| 2022 | 2022-07-31 | $1.3M | −$315,569 | −19.33% |
| 2021 | 2021-07-31 | $1.6M | $1.6M | +7967.37% |
| 2020 | 2020-07-31 | $20,237 | −$23.0M | −99.91% |
| 2019 | 2019-07-31 | $23.0M | — | — |
Odyssey Health quarterly r&d spending
Q1.16
Q2.16
Q3.16
Q1.17
Q2.17
Q3.17
Q1.18
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-07-31 | $0 | — | — |
| Q3 2025 | 2025-04-30 | $0 | $0 | — |
| Q2 2025 | 2025-01-31 | $0 | $0 | — |
| Q1 2025 | 2024-10-31 | $0 | −$23,001 | — |
| Q3 2024 | 2024-04-30 | $0 | $0 | — |
| Q2 2024 | 2024-01-31 | $0 | −$170,000 | — |
| Q1 2024 | 2023-10-31 | $23,001 | −$331,214 | −93.51% |
| Q3 2023 | 2023-04-30 | $0 | −$63,139 | — |
| Q2 2023 | 2023-01-31 | $170,000 | −$290,723 | −63.10% |
| Q1 2023 | 2022-10-31 | $354,215 | $31,711 | +9.83% |
| Q4 2022 | 2022-07-31 | $470,658 | −$553,552 | −54.05% |
| Q3 2022 | 2022-04-30 | $63,139 | −$502,625 | −88.84% |
| Q2 2022 | 2022-01-31 | $460,723 | $418,104 | +981.03% |
| Q1 2022 | 2021-10-31 | $322,504 | $322,504 | — |
| Q4 2021 | 2021-07-31 | $1.0M | — | — |
| Q3 2021 | 2021-04-30 | $565,764 | $565,764 | — |
| Q2 2021 | 2021-01-31 | $42,619 | — | — |
| Q1 2021 | 2020-10-31 | $0 | — | — |
| Q3 2020 | 2020-04-30 | $0 | — | — |
| Q1 2018 | 2017-10-31 | $0 | $0 | — |
| Q3 2017 | 2017-04-30 | $0 | $0 | — |
| Q2 2017 | 2017-01-31 | $0 | $0 | — |
| Q1 2017 | 2016-10-31 | $0 | $0 | — |
| Q3 2016 | 2016-04-30 | $0 | — | — |
| Q2 2016 | 2016-01-31 | $0 | — | — |
| Q1 2016 | 2015-10-31 | $0 | — | — |
Odyssey Health r&d spending trends
Over the last five fiscal years, Odyssey Health's r&d spending decreased from $20,237 to $0, a change of −$20,237. The latest reported quarter, Q4 2025, shows $0.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Odyssey Health source filings ↗